Groundbreaking study paves way for STXBP1 therapies
NCT ID NCT06625112
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 120 people with STXBP1-related disorders, a rare genetic condition causing severe developmental delays and seizures. Researchers aim to track how the disease changes over time and identify the best ways to measure improvement. This work will help design future clinical trials for potential treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STXBP1 ENCEPHALOPATHY WITH EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitair Ziekenhuis Antwerpen
RECRUITINGAntwerp, Belgium
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.